John Kang

Science lover + Scottish fold enthusiast

[HDMZ @HDMZHealth]

Our very own VP of Digital Marketing (@christine_the_bean_) was a guest on @dailyadbrief! You can hear her talk about changes in the digital marketing landscape in her interview here: https://t.co/DeKjzLleKc https://t.co/SFwkAxYfIS

[New England Biolabs @NEBiolabs]

Against the backdrop of its many battles with infectious disease, the Global South applies networking and creative grit to face COVID-19, find out how in this @naturemethods publication. https://t.co/y7SJZQKnIT

[Ron Leuty @rleuty_biotech]

In defining moment, spinout from Nobel Prize winner Jennifer Doudna's lab inks gene therapy deal https://t.co/6ClARAclMW via @SFBusinessTimes

[Fyodor Urnov @UrnovFyodor]

Clinic-bound editing news! Vertex works w CRISPRTx for ex vivo edits (SCD/thal), now brings in new editors for in vivo work.
Gregorspeed, Mammoth!
CoI: personally, zero.
Organizationally: some of the foundational work came out of my University @UCBerkeley and Institute @igisci.

[John Kang @johnkang64]

Mammoth Biosciences Inks $691 Million Deal With Vertex For Crispr Gene-Editing Therapies via @forbes https://t.co/t0V7aFdRAi

[John Kang @johnkang64]

Breakout "#CRISPR platform" company Mammoth Biosciences is officially a unicorn https://t.co/wtoVHQKFb8 via @techcrunch

[John Kang @johnkang64]

How An External Control Arm Changed Phase 3 Trials For Brain Cancer @Medicenna1 $MDNA https://t.co/XjCtpjkXF1

[John Kang @johnkang64]

Already sitting on a major #stemcell bank, @GenerateLifeSci looks to grow its regenerative medicines business - https://t.co/LjuxMcYcyL

[Natera @NateraGenetics]

The market for detecting MRD is soaring, says @Barronsonline, & Natera is leading the charge!

@blalpert explores our latest news, like our recent study published in @Nature, & how it’s propelling us to the top: https://t.co/IEdETPTh4U $NTRA

[John Kang @johnkang64]

New England Biolabs Debuts SARS-CoV-2 Primer Resource as Aid to Combat Variants @tweetMadeleine @NEBiolabs

https://t.co/2SefGw3Bud

[Natera Oncology @NateraOncology]

Read more about the groundbreaking IMvigor010 study results published in @Nature last week in this @GenomeWeb article.

#Oncology #ctDNA #Immunotherapy #BladderCancer #SignateraLooksDeeper

https://t.co/BBa8Apb7j9

[John Kang @johnkang64]

Why Are So Few Life Sciences Companies Certified B Corps? via @forbes https://t.co/1YphBK4pRL
@NEBiolabs

[John Kang @johnkang64]

How Natera Is Defending Its Lead in a $15B Cancer-Testing Market https://t.co/xfd3xWslp2 via @BarronsOnline
$NTRA

[John Kang @johnkang64]

Looking Beyond NIPT, Natera Eyes Cancer, Transplant Testing Growth https://t.co/mE4DGEV8Hz via @GENbio

[STAT @statnews]

Sharon Begley, path-breaking science journalist who spun words into gold, dies at 64
https://t.co/hsqKbXOOKN

[Generate Life Sciences @GenerateLifeSci]

Newborn stem cells from umbilical cord tissue could be used to treat severe COVID-19. Generate Life Science's Chief Medical Officer, Dr. Jaime Shamonki, discusses in this article published in @PharmaReview https://t.co/YahJiI6xTJ

[John Kang @johnkang64]

Could newborn stem cells revolutionise cell therapies? https://t.co/bmkcTxfGU5

[New England Biolabs @NEBiolabs]

Hear from @nebiolabs LAMP expert @nathan_a_tanner about how loop-mediated isothermal amplification can be applied as an alternative nucleic acid amplification method, not just for COIVD-19 detection, but to a broad range of settings. https://t.co/z07WuIPObf

[John Kang @johnkang64]

Addressing the Silent and Deadly Rise of CKD with Genetic Testing https://t.co/WO29EIjoxy

[Natera Oncology @NateraOncology]

Great feature in @GenomeWeb about the INSPIRE study published in @NatureCancer today: https://t.co/78GKEakyHs #ctDNA #SignateraLooksDeeper @ScottBratman